NCT06861569

Brief Summary

The main purpose of this study is to quantitatively evaluate the effect of applying PEEP during the use of SGA on gastric volume, aiming to provide objective evidence regarding the potential side effects, such as gastric volume increase. It is expected that this will contribute to improving the quality of patient management through the safe clinical use of SGA and PEEP.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 6, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

March 15, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2026

Completed
Last Updated

March 6, 2025

Status Verified

April 1, 2024

Enrollment Period

11 months

First QC Date

February 15, 2025

Last Update Submit

March 2, 2025

Conditions

Keywords

Supraglottic Airway DevicePostive End Expiratory PressureGastric Sonography

Outcome Measures

Primary Outcomes (1)

  • Gastric volume difference before and after surgery

    Before and after the surgery, the patient is positioned in a sitting position and then in the right lateral decubitus (RLD) position. Ultrasound is used to measure the cross-sectional area (CSA) of the gastric antrum and then it is substituted into the following equation to estimate gastric volume. GV (ml) = 27.0 + 14.6 × CSAright-lat - 1.28×age The scanning is performed three times for each position to obtain the average value.

    Baseline and end of surgery 0 minute

Secondary Outcomes (14)

  • Fraction of Inspired Oxygen

    5 minutes, 30 minutes, 60 minutes after SGA insertion

  • Peak Inspiratory pressure

    5 minutes, 30 minutes, 60 minutes after SGA insertion

  • Respiratory rate

    5 minutes, 30 minutes, 60 minutes after SGA insertion

  • Lung compliance

    5 minutes, 30 minutes, 60 minutes after SGA insertion

  • Oxygen Saturation

    5 minutes, 30 minutes, 60 minutes after SGA insertion

  • +9 more secondary outcomes

Study Arms (2)

ZEEP

NO INTERVENTION

Patients undergoing general anesthesia using supraglottic airway device without PEEP.

PEEP

EXPERIMENTAL

Patients undergoing general anesthesia using supraglottic airway device with PEEP of 5cmH2O.

Procedure: Positive end expiratory pressure

Interventions

Positive end-expiratory pressure (PEEP) is a value that can be set up in patients receiving invasive or non-invasive mechanical ventilation. 5cmH2O PEEP will be applied to the PEEP group participants.

PEEP

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients aged 19 and above.
  • Patients scheduled for general anesthesia for elective surgery.
  • American society of anesthesiologists physical status classification 1 or 2

You may not qualify if:

  • Individuals who have not provided prior consent for participation in the study
  • Patients showing cognitive impairment to the extent that voluntary consent is difficult
  • Obesity with a BMI of 30 kg/m² or higher
  • Patients with anatomical abnormalities in the airway structure making supraglottic airway device application difficult
  • Patients with respiratory diseases making PEEP application difficult (e.g., chronic obstructive pulmonary disease, asthma)
  • Patients suspected of delayed gastric emptying (e.g., not adhering to fasting guidelines, medication use affecting gastric motility \[anticholinergics, narcotic analgesics\], neurological disorders \[Parkinson's disease, multiple sclerosis\], diabetes, hypothyroidism)
  • Patients with a history of gastrointestinal surgery
  • Pregnant women
  • Patients undergoing concurrent surgeries or collaborative procedures
  • Patients transferred from the intensive care unit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Positive-Pressure Respiration

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Bon Wook Koo

    Seoul National University Bundang Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 15, 2025

First Posted

March 6, 2025

Study Start

March 15, 2025

Primary Completion

February 1, 2026

Study Completion

February 2, 2026

Last Updated

March 6, 2025

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL